Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Toxicoinformatics: The Master Key for Toxicogenomics

  • Published : 2005.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The current vision of toxicogenomics is the development of methods or platforms to predict toxicity of un characterized chemicals by using '-omics' information in pre-clinical stage. Because each chemical has different ADME (absorption, distribution, mechanism, excretion) and experimental animals have lots of variation, precise prediction of chemical's toxicity based on '-omics' information and toxicity data of known chemicals is very difficult problem. So, the importance of bioinformatics is more emphasized on toxicogenomics than other functional genomics studies because these problems can not be solved only with experiments. Thus, toxicoinformatics covers all information-based analytical methods from gene expression (bioinformatics) to chemical structures (cheminformatics) and it also deals with the integration of wide range of experimental data for further extensive analyses. In this review, the overall strategy to toxicoinformatics is discussed.

Keywords

References

  1. Roos, D.S. Computational biology. Bioinformatics-- trying to swim in a sea of data. Science 291, 1260-1 (2001) https://doi.org/10.1126/science.291.5507.1260
  2. Kanehisa, M. & Bork, P. Bioinformatics in the postsequence era. Nat Genet. 33 Suppl, 305-10 (2003) https://doi.org/10.1038/ng1109
  3. Guerreiro, N., Staedtler, F., Grenet, O., Kehren, J. & Chibout, S.D. Toxicogenomics in drug development. Toxicol Pathol. 31, 471-9 (2003) https://doi.org/10.1080/01926230390224656
  4. Suter, L., Babiss, L.E. & Wheeldon, E.B. Toxicogenomics in predictive toxicology in drug development. Chem Biol. 11, 161-71 (2004) https://doi.org/10.1016/j.chembiol.2004.02.003
  5. Yang, Y., Blomme, E.A. & Waring, J.F. Toxicogenomics in drug discovery: from preclinical studies to clinical trials. Chem Biol Interact. 150, 71-85 (2004). https://doi.org/10.1016/j.cbi.2004.09.013
  6. Lakkis, M.M., DeCristofaro, M.F., Ahr, H.J. & Mansfield, T.A. Application of toxicogenomics to drug development. Expert Rev Mol Diagn. 2, 337-45 (2002) https://doi.org/10.1586/14737159.2.4.337
  7. Mattingly, C.J., Colby, G.T., Rosenstein, M.C., Forrest, J.N., Jr. & Boyer, J.L. Promoting comparative molecular studies in environmental health research: an overview of the comparative toxicogenomics database (CTD). Pharmacogenomics. 4, 5-8 (2004) https://doi.org/10.1038/sj.tpj.6500225
  8. Mattingly, C.J., Colby, G.T., Forrest, J.N. & Boyer, J. L. The Comparative Toxicogenomics Database (CTD). Environ Health Perspect. 111, 793-5 (2003) https://doi.org/10.1289/ehp.6028
  9. Tong, W. et al. ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect. 111, 1819-26 (2003) https://doi.org/10.1289/ehp.6497
  10. Eisen, M. B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci. USA 95, 14863-8 (1998)
  11. Lu, Y., Lu, S., Fotouhi, F., Deng, Y. & Brown, S.J. Incremental genetic K-means algorithm and its application in gene expression data analysis. BMC Bioinformatics. 5, 172 (2004)
  12. P. Tamayo et al. Interpreting patterns of gene expression with SOMs-methods and application to hematopoietic differentiation. Proc. Natl Acad. Sci. USA, 96, 2907-2912 (1999)
  13. Lee, S.G., Hur, J.U. & Kim, Y.S. A graph-theoretic modeling on GO space for biological interpretation of gene clusters. Bioinformatics. 20, 381-8 (2004) https://doi.org/10.1093/bioinformatics/btg420
  14. Dahlquist, K.D., Salomonis, N., Vranizan, K., Lawlor, S.C. & Conklin, B.R. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet. 31, 19-20 (2002) https://doi.org/10.1038/ng0502-19
  15. Kanehisa, M., Goto, S., Kawashima, S., Okuno, Y. & Hattori, M. The KEGG resource for deciphering the genome. Nucleic Acids Res. 32, D277-80 (2004) https://doi.org/10.1093/nar/gkh063
  16. Kanehisa, M. The KEGG database. Novartis Found Symp. 247, 91-101 discussion 101-3, 119-28, 244-52 (2002)
  17. http://www.istech.info/ToxGate/
  18. Knudsen, T. B. & Daston, G. P. MIAME guidelines. Reprod Toxicol. 19, 263 (2005)